Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections

September 2013

Oral ketoconazole (Nizoral, etc) will continue to fall out of favor for fungal infections...due to stronger labeling restrictions.

It's no longer approved for skin infections due to the risk of hepatotoxicity, adrenal insufficiency, and serious drug interactions.

And it will probably be withdrawn in Europe.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote